Search

Displaying results 3001 - 3010 of 10000 in total
  1. Drug

    Loteprednol etabonate

    go.drugbank.com/drugs/DB14596
    Approved

    A number of such new formulations that have been approved include Kala Pharmaceutical's Inveltys - the first twice-daily (BID) ocular corticosteroid approved for this indication, designed specifically

  2. Indication

    HER2-positive Unresectable Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0173516
    Drugs: Zongertinib
    Synonyms: HER2-positive Unresectable Non-Small Cell Lung Cancer (NSCLC)
  3. Indication

    Inflammatory Reaction caused by ear infection-not otherwise specified

    go.drugbank.com/conditions/DBCOND0134823
    Drugs: Lidocaine
    Synonyms: Inflammatory Reaction caused by ear infection-not otherwise specified
  4. Indication

    Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

    go.drugbank.com/conditions/DBCOND0130015
    Drugs: Glofitamab · Loncastuximab tesirine · Polatuzumab vedotin · Selinexor · Tafasitamab
    Synonyms: Refractory Diffuse large B-cell lymphoma NOS, Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  5. Indication

    High risk BCG-unresponsive non-muscle invasive bladder cancer

    go.drugbank.com/conditions/DBCOND0153571
    Drugs: Nadofaragene firadenovec
    Synonyms: High risk BCG-unresponsive non-muscle invasive bladder cancer
  6. Indication

    Locally advanced EGFR Positive Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0173471
    Drugs: Datopotamab deruxtecan
    Synonyms: Locally advanced EGFR Positive Non-small Cell Lung Cancer
  7. Indication

    Refractory, metastatic squamous cell Non-small cell lung cancer

    go.drugbank.com/conditions/DBCOND0023505
    Drugs: Afatinib
    Synonyms: Refractory, metastatic squamous cell Non-small cell lung cancer, Refractory, metastatic Squamous Cell Cancer Non-Small Cell Lung Cancer
  8. Indication

    Stage 3 Locally Advanced Non-Small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0173359
    Drugs: Durvalumab
    Synonyms: Stage 3 Locally Advanced Non-Small Cell Lung Cancer
  9. Indication

    Unresectable, locally advanced Non-Small Cell Lung Carcinoma (NSCLC)

    go.drugbank.com/conditions/DBCOND0149211
    Drugs: Capmatinib
    Synonyms: Unresectable, locally advanced Non-Small Cell Lung Carcinoma (NSCLC)
  10. Drug

    Anagrelide

    go.drugbank.com/drugs/DB00261
    ApprovedInvestigational

    [busulfan], [hydroxyurea]) and may be better tolerated.[A214274]